Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Menke

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 10, 2007
Pheochromocytoma mimicking an acute myocardial infarctionC W Menke-van der Houven van Oordt, Th B Twickler, F G M H van Asperdt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 27, 2020
A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumoursFlorence Atrafi, Herlinde Dumez, Ron H J Mathijssen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 27, 2021
Biodistribution of <sup>18</sup>F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER DegraderRamsha Iqbal, Maqsood Yaqub, Daniela E Oprea-Lager, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2018
Radiomics analysis of pre-treatment [<sup>18</sup>F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatmentE J van Helden, Y J L Vacher, W N van Wieringen, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Diagnostic Performance of [<sup>18</sup>F]FDG PET in Staging Grade 1-2, Estrogen Receptor Positive Breast CancerRamsha Iqbal, Lemonitsa H Mammatas, Tuba Aras, et al.
Hormones & Cancer|July 17, 2016
Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal NetworkM H T Ettaieb, J C Duker, R A Feelders, et al.
Oncotarget|May 8, 2018
Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysisRobin W Jansen, Paul van Amstel, Roland M Martens, et al.
British Journal of Cancer|July 2, 2014
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastasesJ A C M Goos, A C Hiemstra, V M H Coupé, et al.
Breast (Edinburgh, Scotland)|December 14, 2025
Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patientsJ Meijer, H J G D van den Bongard, L B Koppert, et al.
The American Journal of Surgical Pathology|July 9, 2019
Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 ResultsSuzanne C van Es, Bert van der Vegt, Frederike Bensch, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 10, 2007
Pheochromocytoma mimicking an acute myocardial infarctionC W Menke-van der Houven van Oordt, Th B Twickler, F G M H van Asperdt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 27, 2020
A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumoursFlorence Atrafi, Herlinde Dumez, Ron H J Mathijssen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 27, 2021
Biodistribution of <sup>18</sup>F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER DegraderRamsha Iqbal, Maqsood Yaqub, Daniela E Oprea-Lager, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2018
Radiomics analysis of pre-treatment [<sup>18</sup>F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatmentE J van Helden, Y J L Vacher, W N van Wieringen, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Diagnostic Performance of [<sup>18</sup>F]FDG PET in Staging Grade 1-2, Estrogen Receptor Positive Breast CancerRamsha Iqbal, Lemonitsa H Mammatas, Tuba Aras, et al.
Hormones & Cancer|July 17, 2016
Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal NetworkM H T Ettaieb, J C Duker, R A Feelders, et al.
Oncotarget|May 8, 2018
Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysisRobin W Jansen, Paul van Amstel, Roland M Martens, et al.
British Journal of Cancer|July 2, 2014
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastasesJ A C M Goos, A C Hiemstra, V M H Coupé, et al.
Breast (Edinburgh, Scotland)|December 14, 2025
Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patientsJ Meijer, H J G D van den Bongard, L B Koppert, et al.
The American Journal of Surgical Pathology|July 9, 2019
Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 ResultsSuzanne C van Es, Bert van der Vegt, Frederike Bensch, et al.
Pageof 8